Laura

Administrator
Administrator
Moderator
FOTCM Member

James Lyons-Weiler, PhD – 1/30/2020


RECOMBINATION technology has been in use in molecular virology since the 1980’s. The structure of the 2019-NCoV virus genome provides a very strong clue on the likely origin of the virus.

Unlike other related coronaviruses, the 2019-nCoV virus has a unique sequence about 1,378 bp (nucleotide base pairs) long that is not found in related coronaviruses.

Looking at the phylogenetic tree recently published derived using all the full genome sequence, we see the 2019-nCoV virus does not have clear monophyletic support given the bootstrap value of 75 (Fig 1).

Close-up on Bootstrap value of 75 for available 2019-nCoV from Lu et al., 2020 The Lancet article [Full Text]
There is no doubt that there is a novel sequence in 2019-nCoV; we confirmed this via sequence alignment. Here’s the DOT plot:

Dot-Plot.png

The gap in the line shows a lack of sequence homology beween the most similar bat coronavirus and 2019-nCoV. The inserted sequence, which should not be there is here:

inserted-portionDownload

A database search by the first team to study and publish the whole genome sequence for the origins of the inserted sequence turned up no hits (Ji et al., 2020). They conducted a codon-bias analysis which led them to speculate that perhaps there had been a recombination event between a coronavirus in snakes with a coronavirus from bats (Ji et al., 2020). [Full Text]

This led to criticism on Wired(3) with quote dismissing the snake origin hypothesis as lacking evidence. There is, however, clear evidence that the novel sequence, which I will refer to henceforth as INS1378, is from a laboratory-induced recombination event. Specifically,

(1) The sequence similarity to other coronavirus sequences is lower to its most similar sequences in any coronavirus than the rest of the genome (IPAK finding)

(2) The high sequence similarity of INS1378 to a SARS spike protein (2; IPAK Confirmed).

(3) We also found significant sequence similarity of INS1378 to a pShuttle-SN vector that was in use in the 1980’s in China to create a more immunogenic coronavirus (IPAK finding, details below, Option 4).


Here, I review four Option on the origins of the 2019-nCoV Coronavirus isolated from human patients from Wuhan, China.


Option 1. Natural coronavirus related to bat coronaviruses, Not a Recombined Virus
.

Evidence for: Phylogenetic clustering with Bat coronaviruses.

Evidence against: Low bootstrap support (N=75) and presence of a INS1378.

Status: Falsified hypothesis.

Test: Survey coronviruses in animals in the wild.


Option 2. A recombined virus that naturally picked up a SARS-like spike protein in it N-terminus (3′ end) of the viral genome.

Evidence for: The INS1378 codon bias similar to snakes ($)

Evidence against: Insufficient match in database search to other known CoV spike proteins (Ji et al., 2020)

Status: Speculative hypothesis. Unlikely.

Test: Find an isolate that matches 2019-nCoV in the wild and reproducibly independently isolate the virus from a wild animal (a match will confirm).

Option 3. A recombined virus made in a laboratory for the purpose of creating a bioweapon.

Both China and the US hinted at the other side’s potential liability in playing a role in bringing about a novel coronavirus in the lab specifically for the purpose of being used as a bioweapon. To add to the intrigue, a Chinese Scientist was released from BSL-4 laboratory in Manitoba, Canada for violating protocols, allegedly sending samples of deadly viruses to mainland China.

Evidence for: Presence of BSL-4 laboratory 20 miles from the Wuhan seafood market

Evidence against: Published opinion.

Status: Rumor. But see below.


Option 4. A recombined virus made in a laboratory for the purpose of creating a vaccine.

IPAK researchers found a sequence similarity between a pShuttle-SN recombination vector sequence and INS1378. Here’s a shot of the alignment and the DOT Plot.

Wuhan_pshuttle.jpg

Here’s the nucleotide sequence at NCBI’s Nucleotide database. Here’s a patent for its use in recombination virology.

The pShuttle-SN vector was among many described in a 1998 paper by Bert Vogelstein et al; here is a company where one can purchase the pShuttle-SN vector:



It turns out that the sequence from pShuttle is most closely related to the Spike protein from SARS coronavirus.

spike-protein-tree.jpg

This particular technology was used in 2008 to attempt to develop a more immunogenic vaccine against coronavirus. Here’s a Chinese patent for that technique and product intended for use in a vaccine.

The patent summary reads:

SARS vaccine of adenovirus vector and preparation method, application of coronavirus S gene
Abstract
(translated from Chinese)
The present invention belongs to the field of genetic engineering, particularly relates to adenoviral vector SARS vaccines, their preparation and coronavirus S genes in SARS (SARS) on vaccines for the prophylaxis. By means of biological engineering, the coronavirus S gene in combination with deficient recombinant adenovirus, the protective immunogen protein or polypeptide expressed therein, through expansion culture, purification, and formulation to prepare a mucosal immunogenicity can cause the gene vaccine, respiratory mucosal immune response induced by the body to produce antibodies against the virus infection. Specific conditions of the present invention, compared with conventional inactivated virus particle vaccine, safe, easy to use, without limitation intramuscular, have broad clinical applications.

In 2015, The US called for an end to research creating new viruses in the lab that have increased threat (higher transmissibility, higher pathogenicity, higher lethalithy) (3)


The very researchers conducting studies on SARS vaccines have cautioned repeatedly against human trials;

“An early concern for application of a SARS-CoV vaccine was the experience with other coronavirus infections which induced enhanced disease and immunopathology in animals when challenged with infectious virus [31], a concern reinforced by the report that animals given an alum adjuvanted SARS vaccine and subsequently challenged with SARS-CoV exhibited an immunopathologic lung reaction reminiscent of that described for respiratory syncytial virus (RSV) in infants and in animal models given RSV vaccine and challenged naturally (infants) or artificially (animals) with RSV [32], [33]. We and others described a similar immunopathologic reaction in mice vaccinated with a SARS-CoV vaccine and subsequently challenged with SARS-CoV [18], [20], [21], [28]. It has been proposed that the nucleocapsid protein of SARS-CoV is the antigen to which the immunopathologic reaction is directed [18], [21]. Thus, concern for proceeding to humans with candidate SARS-CoV vaccines emerged from these various observations.” – Tseng et al.,

The disease progression in of 2019-nCoV is consistent with those seen in animals and humans vaccinated against SARS and then challenged with re-infection. Thus, the hypothesis that 2019-nCoV is an experimental vaccine type must be seriously considered.

Evidence for: Sequence homology between INS1378 to pShuttle Coronavirus vaccine; presence of a SARS-like Spike protein in bat coronavirus, otherwise most similar to bat coronaviruses; low bootstrap value.

Evidence against: Low sequence homology (but highly signifiant). NB these viruses are RNA viruses and they can evolve quickly, even under laboratory conditions.

Status: Most likely.

Test: Determine the nucleotide sequence all laboratory types of coronavirus being studied in China (a match will confirm). Find an isolate that matches 2019-nCoV in the wild and reproducibly independently isolate the virus from a wild animal (a match will falsify).

The available evidence most strongly supports that the 2019-NCoV virus is a vaccine strain of coronavirus either accidentally released from a laboratory accident, perhaps a laboratory researcher becoming infected with the virus while conducting animal experiments, or the Chinese were performing clinical studies of a Coronavirus vaccine in humans.

Dr. Dale Brown brought to my attention the studies that have reported serious immunopathology in animals – rats, ferrets, and monkeys – in which animals vaccinated against coronoviruses tended to have extremely high rates of respiratory failure upon subsequent exposure in the study when challenged with the wild-type coronavirus.

TeEtal2012.jpg


“Caution in proceeding to application of a SARS-CoV vaccine in humans is indicated”- Te et al., 2012 [Full Text]
Yasui et al., (2012) reported severe pneumonia in mice who were vaccinated against SARS who were subsequently infected with SARS.

Another study of a double-inactived SARS vaccine found increased eosinophilic proinflammatory responses in vaccinated mice, especially older mice, writing:

“Importantly, aged animals displayed increased eosinophilic immune pathology in the lungs and were not protected against significant virus replication.”

If the Chinese government has been conducting human trials against SARS. MERS, or other coronviruses using recombined viruses, they may have made their citizens far more susceptible to acute respiratory distress syndrome upon infection with 2019-nCoV coronavirus.

The implications are clear: if China sensitized their population via a SARS vaccine, and this escaped from a lab, the rest of world has a serious humanitarian urgency to help China, but may not expect as serious an epidemic as might otherwise be expected.


In the worst-case scenario, if the vaccination strain is more highly contagious and lethal, 2019-nCoV could become the worst example of vaccine-derived contagious disease in human history. With an uncharacteristic aysmptomatic prodromal period of 5-7 days, individuals returning from China to other countries must be forthright and cooperative in their now-prescribed 2-week quarantine.
 

Stoneboss

Jedi Master
FOTCM Member

James Lyons-Weiler, PhD – 1/30/2020


RECOMBINATION technology has been in use in molecular virology since the 1980’s. The structure of the 2019-NCoV virus genome provides a very strong clue on the likely origin of the virus.

Unlike other related coronaviruses, the 2019-nCoV virus has a unique sequence about 1,378 bp (nucleotide base pairs) long that is not found in related coronaviruses.

Looking at the phylogenetic tree recently published derived using all the full genome sequence, we see the 2019-nCoV virus does not have clear monophyletic support given the bootstrap value of 75 (Fig 1).

Close-up on Bootstrap value of 75 for available 2019-nCoV from Lu et al., 2020 The Lancet article [Full Text]
There is no doubt that there is a novel sequence in 2019-nCoV; we confirmed this via sequence alignment. Here’s the DOT plot:

Dot-Plot.png

The gap in the line shows a lack of sequence homology beween the most similar bat coronavirus and 2019-nCoV. The inserted sequence, which should not be there is here:

inserted-portionDownload

A database search by the first team to study and publish the whole genome sequence for the origins of the inserted sequence turned up no hits (Ji et al., 2020). They conducted a codon-bias analysis which led them to speculate that perhaps there had been a recombination event between a coronavirus in snakes with a coronavirus from bats (Ji et al., 2020). [Full Text]

This led to criticism on Wired(3) with quote dismissing the snake origin hypothesis as lacking evidence. There is, however, clear evidence that the novel sequence, which I will refer to henceforth as INS1378, is from a laboratory-induced recombination event. Specifically,

(1) The sequence similarity to other coronavirus sequences is lower to its most similar sequences in any coronavirus than the rest of the genome (IPAK finding)

(2) The high sequence similarity of INS1378 to a SARS spike protein (2; IPAK Confirmed).

(3) We also found significant sequence similarity of INS1378 to a pShuttle-SN vector that was in use in the 1980’s in China to create a more immunogenic coronavirus (IPAK finding, details below, Option 4).


Here, I review four Option on the origins of the 2019-nCoV Coronavirus isolated from human patients from Wuhan, China.


Option 1. Natural coronavirus related to bat coronaviruses, Not a Recombined Virus
.

Evidence for: Phylogenetic clustering with Bat coronaviruses.

Evidence against: Low bootstrap support (N=75) and presence of a INS1378.

Status: Falsified hypothesis.

Test: Survey coronviruses in animals in the wild.


Option 2. A recombined virus that naturally picked up a SARS-like spike protein in it N-terminus (3′ end) of the viral genome.

Evidence for: The INS1378 codon bias similar to snakes ($)

Evidence against: Insufficient match in database search to other known CoV spike proteins (Ji et al., 2020)

Status: Speculative hypothesis. Unlikely.

Test: Find an isolate that matches 2019-nCoV in the wild and reproducibly independently isolate the virus from a wild animal (a match will confirm).

Option 3. A recombined virus made in a laboratory for the purpose of creating a bioweapon.

Both China and the US hinted at the other side’s potential liability in playing a role in bringing about a novel coronavirus in the lab specifically for the purpose of being used as a bioweapon. To add to the intrigue, a Chinese Scientist was released from BSL-4 laboratory in Manitoba, Canada for violating protocols, allegedly sending samples of deadly viruses to mainland China.

Evidence for: Presence of BSL-4 laboratory 20 miles from the Wuhan seafood market

Evidence against: Published opinion.

Status: Rumor. But see below.


Option 4. A recombined virus made in a laboratory for the purpose of creating a vaccine.

IPAK researchers found a sequence similarity between a pShuttle-SN recombination vector sequence and INS1378. Here’s a shot of the alignment and the DOT Plot.

Wuhan_pshuttle.jpg

Here’s the nucleotide sequence at NCBI’s Nucleotide database. Here’s a patent for its use in recombination virology.

The pShuttle-SN vector was among many described in a 1998 paper by Bert Vogelstein et al; here is a company where one can purchase the pShuttle-SN vector:



It turns out that the sequence from pShuttle is most closely related to the Spike protein from SARS coronavirus.

spike-protein-tree.jpg

This particular technology was used in 2008 to attempt to develop a more immunogenic vaccine against coronavirus. Here’s a Chinese patent for that technique and product intended for use in a vaccine.

The patent summary reads:



In 2015, The US called for an end to research creating new viruses in the lab that have increased threat (higher transmissibility, higher pathogenicity, higher lethalithy) (3)


The very researchers conducting studies on SARS vaccines have cautioned repeatedly against human trials;

“An early concern for application of a SARS-CoV vaccine was the experience with other coronavirus infections which induced enhanced disease and immunopathology in animals when challenged with infectious virus [31], a concern reinforced by the report that animals given an alum adjuvanted SARS vaccine and subsequently challenged with SARS-CoV exhibited an immunopathologic lung reaction reminiscent of that described for respiratory syncytial virus (RSV) in infants and in animal models given RSV vaccine and challenged naturally (infants) or artificially (animals) with RSV [32], [33]. We and others described a similar immunopathologic reaction in mice vaccinated with a SARS-CoV vaccine and subsequently challenged with SARS-CoV [18], [20], [21], [28]. It has been proposed that the nucleocapsid protein of SARS-CoV is the antigen to which the immunopathologic reaction is directed [18], [21]. Thus, concern for proceeding to humans with candidate SARS-CoV vaccines emerged from these various observations.” – Tseng et al.,

The disease progression in of 2019-nCoV is consistent with those seen in animals and humans vaccinated against SARS and then challenged with re-infection. Thus, the hypothesis that 2019-nCoV is an experimental vaccine type must be seriously considered.

Evidence for: Sequence homology between INS1378 to pShuttle Coronavirus vaccine; presence of a SARS-like Spike protein in bat coronavirus, otherwise most similar to bat coronaviruses; low bootstrap value.

Evidence against: Low sequence homology (but highly signifiant). NB these viruses are RNA viruses and they can evolve quickly, even under laboratory conditions.

Status: Most likely.

Test: Determine the nucleotide sequence all laboratory types of coronavirus being studied in China (a match will confirm). Find an isolate that matches 2019-nCoV in the wild and reproducibly independently isolate the virus from a wild animal (a match will falsify).

The available evidence most strongly supports that the 2019-NCoV virus is a vaccine strain of coronavirus either accidentally released from a laboratory accident, perhaps a laboratory researcher becoming infected with the virus while conducting animal experiments, or the Chinese were performing clinical studies of a Coronavirus vaccine in humans.

Dr. Dale Brown brought to my attention the studies that have reported serious immunopathology in animals – rats, ferrets, and monkeys – in which animals vaccinated against coronoviruses tended to have extremely high rates of respiratory failure upon subsequent exposure in the study when challenged with the wild-type coronavirus.

TeEtal2012.jpg


“Caution in proceeding to application of a SARS-CoV vaccine in humans is indicated”- Te et al., 2012 [Full Text]
Yasui et al., (2012) reported severe pneumonia in mice who were vaccinated against SARS who were subsequently infected with SARS.

Another study of a double-inactived SARS vaccine found increased eosinophilic proinflammatory responses in vaccinated mice, especially older mice, writing:

“Importantly, aged animals displayed increased eosinophilic immune pathology in the lungs and were not protected against significant virus replication.”

If the Chinese government has been conducting human trials against SARS. MERS, or other coronviruses using recombined viruses, they may have made their citizens far more susceptible to acute respiratory distress syndrome upon infection with 2019-nCoV coronavirus.

The implications are clear: if China sensitized their population via a SARS vaccine, and this escaped from a lab, the rest of world has a serious humanitarian urgency to help China, but may not expect as serious an epidemic as might otherwise be expected.


In the worst-case scenario, if the vaccination strain is more highly contagious and lethal, 2019-nCoV could become the worst example of vaccine-derived contagious disease in human history. With an uncharacteristic aysmptomatic prodromal period of 5-7 days, individuals returning from China to other countries must be forthright and cooperative in their now-prescribed 2-week quarantine.

I watched most of this video (linked below) last night. At the 23 minute mark of the video, James Lyons-Weiler is being interviewed at talks about what this article is all about. Very interesting.

Also, around the 60 minute mark, Dr. David Brownstein is interviewed saying how important it is to take iodine (as well as other things) to combat viruses.

 

nature

Dagobah Resident
[...] The available evidence most strongly supports that the 2019-NCoV virus is a vaccine strain of coronavirus either accidentally released from a laboratory accident, perhaps a laboratory researcher becoming infected with the virus while conducting animal experiments, or the Chinese were performing clinical studies of a Coronavirus vaccine in humans.
[...]
Interesting review you made, Laura.
It meets what is seen with flu vaccine

New York boy, 11, dies of flu virus that attacked his heart despite getting the flu shot that NIH doctors say is a 'mismatch for kids'


I would say that the vaccine is probably what killed the boy.
 

liam1310

Jedi Council Member
FOTCM Member
The man travelled to the Philippines from Wuhan, via Hong Kong, with a 38-year-old Chinese woman who also tested positive last week, the Philippines Department of Health said.

Officials said he was admitted to a hospital in the capital, Manila, where he developed severe pneumonia.

The man is thought to have had other pre-existing health conditions

 

liam1310

Jedi Council Member
FOTCM Member
Hong Kong reported its first death from the coronavirus on Tuesday - only the second outside China - as the death toll from the outbreak rose to at least 425 and China admitted "shortcomings and difficulties" in its response to the flu-like infection.


The Hong Kong victim was a 39-year-old man from Wuhan, where the virus first originated, who had underlying health problems, the authorities said. It was the second death recorded outside China - the first was in the Philippines on Sunday.


Meanwhile, China's National Health Commission reported 64 new fatalities as of midnight on Monday - the biggest daily increase since the virus was first detected late last year. Wuhan, and the surrounding province of Hubei, have been effectively sealed off from the rest of the country for more than a week.

 

Woodsman

The Living Force
FOTCM Member

James Lyons-Weiler, PhD – 1/30/2020


RECOMBINATION technology has been in use in molecular virology since the 1980’s. The structure of the 2019-NCoV virus genome provides a very strong clue on the likely origin of the virus.

Unlike other related coronaviruses, the 2019-nCoV virus has a unique sequence about 1,378 bp (nucleotide base pairs) long that is not found in related coronaviruses.

Looking at the phylogenetic tree recently published derived using all the full genome sequence, we see the 2019-nCoV virus does not have clear monophyletic support given the bootstrap value of 75 (Fig 1).

Close-up on Bootstrap value of 75 for available 2019-nCoV from Lu et al., 2020 The Lancet article [Full Text]
There is no doubt that there is a novel sequence in 2019-nCoV; we confirmed this via sequence alignment. Here’s the DOT plot:

Dot-Plot.png

The gap in the line shows a lack of sequence homology beween the most similar bat coronavirus and 2019-nCoV. The inserted sequence, which should not be there is here:

inserted-portionDownload

A database search by the first team to study and publish the whole genome sequence for the origins of the inserted sequence turned up no hits (Ji et al., 2020). They conducted a codon-bias analysis which led them to speculate that perhaps there had been a recombination event between a coronavirus in snakes with a coronavirus from bats (Ji et al., 2020). [Full Text]

This led to criticism on Wired(3) with quote dismissing the snake origin hypothesis as lacking evidence. There is, however, clear evidence that the novel sequence, which I will refer to henceforth as INS1378, is from a laboratory-induced recombination event. Specifically,

(1) The sequence similarity to other coronavirus sequences is lower to its most similar sequences in any coronavirus than the rest of the genome (IPAK finding)

(2) The high sequence similarity of INS1378 to a SARS spike protein (2; IPAK Confirmed).

(3) We also found significant sequence similarity of INS1378 to a pShuttle-SN vector that was in use in the 1980’s in China to create a more immunogenic coronavirus (IPAK finding, details below, Option 4).


Here, I review four Option on the origins of the 2019-nCoV Coronavirus isolated from human patients from Wuhan, China.


Option 1. Natural coronavirus related to bat coronaviruses, Not a Recombined Virus
.

Evidence for: Phylogenetic clustering with Bat coronaviruses.

Evidence against: Low bootstrap support (N=75) and presence of a INS1378.

Status: Falsified hypothesis.

Test: Survey coronviruses in animals in the wild.


Option 2. A recombined virus that naturally picked up a SARS-like spike protein in it N-terminus (3′ end) of the viral genome.

Evidence for: The INS1378 codon bias similar to snakes ($)

Evidence against: Insufficient match in database search to other known CoV spike proteins (Ji et al., 2020)

Status: Speculative hypothesis. Unlikely.

Test: Find an isolate that matches 2019-nCoV in the wild and reproducibly independently isolate the virus from a wild animal (a match will confirm).

Option 3. A recombined virus made in a laboratory for the purpose of creating a bioweapon.

Both China and the US hinted at the other side’s potential liability in playing a role in bringing about a novel coronavirus in the lab specifically for the purpose of being used as a bioweapon. To add to the intrigue, a Chinese Scientist was released from BSL-4 laboratory in Manitoba, Canada for violating protocols, allegedly sending samples of deadly viruses to mainland China.

Evidence for: Presence of BSL-4 laboratory 20 miles from the Wuhan seafood market

Evidence against: Published opinion.

Status: Rumor. But see below.


Option 4. A recombined virus made in a laboratory for the purpose of creating a vaccine.

IPAK researchers found a sequence similarity between a pShuttle-SN recombination vector sequence and INS1378. Here’s a shot of the alignment and the DOT Plot.

Wuhan_pshuttle.jpg

Here’s the nucleotide sequence at NCBI’s Nucleotide database. Here’s a patent for its use in recombination virology.

The pShuttle-SN vector was among many described in a 1998 paper by Bert Vogelstein et al; here is a company where one can purchase the pShuttle-SN vector:



It turns out that the sequence from pShuttle is most closely related to the Spike protein from SARS coronavirus.

spike-protein-tree.jpg

This particular technology was used in 2008 to attempt to develop a more immunogenic vaccine against coronavirus. Here’s a Chinese patent for that technique and product intended for use in a vaccine.

The patent summary reads:



In 2015, The US called for an end to research creating new viruses in the lab that have increased threat (higher transmissibility, higher pathogenicity, higher lethalithy) (3)


The very researchers conducting studies on SARS vaccines have cautioned repeatedly against human trials;

“An early concern for application of a SARS-CoV vaccine was the experience with other coronavirus infections which induced enhanced disease and immunopathology in animals when challenged with infectious virus [31], a concern reinforced by the report that animals given an alum adjuvanted SARS vaccine and subsequently challenged with SARS-CoV exhibited an immunopathologic lung reaction reminiscent of that described for respiratory syncytial virus (RSV) in infants and in animal models given RSV vaccine and challenged naturally (infants) or artificially (animals) with RSV [32], [33]. We and others described a similar immunopathologic reaction in mice vaccinated with a SARS-CoV vaccine and subsequently challenged with SARS-CoV [18], [20], [21], [28]. It has been proposed that the nucleocapsid protein of SARS-CoV is the antigen to which the immunopathologic reaction is directed [18], [21]. Thus, concern for proceeding to humans with candidate SARS-CoV vaccines emerged from these various observations.” – Tseng et al.,

The disease progression in of 2019-nCoV is consistent with those seen in animals and humans vaccinated against SARS and then challenged with re-infection. Thus, the hypothesis that 2019-nCoV is an experimental vaccine type must be seriously considered.

Evidence for: Sequence homology between INS1378 to pShuttle Coronavirus vaccine; presence of a SARS-like Spike protein in bat coronavirus, otherwise most similar to bat coronaviruses; low bootstrap value.

Evidence against: Low sequence homology (but highly signifiant). NB these viruses are RNA viruses and they can evolve quickly, even under laboratory conditions.

Status: Most likely.

Test: Determine the nucleotide sequence all laboratory types of coronavirus being studied in China (a match will confirm). Find an isolate that matches 2019-nCoV in the wild and reproducibly independently isolate the virus from a wild animal (a match will falsify).

The available evidence most strongly supports that the 2019-NCoV virus is a vaccine strain of coronavirus either accidentally released from a laboratory accident, perhaps a laboratory researcher becoming infected with the virus while conducting animal experiments, or the Chinese were performing clinical studies of a Coronavirus vaccine in humans.

Dr. Dale Brown brought to my attention the studies that have reported serious immunopathology in animals – rats, ferrets, and monkeys – in which animals vaccinated against coronoviruses tended to have extremely high rates of respiratory failure upon subsequent exposure in the study when challenged with the wild-type coronavirus.

TeEtal2012.jpg


“Caution in proceeding to application of a SARS-CoV vaccine in humans is indicated”- Te et al., 2012 [Full Text]
Yasui et al., (2012) reported severe pneumonia in mice who were vaccinated against SARS who were subsequently infected with SARS.

Another study of a double-inactived SARS vaccine found increased eosinophilic proinflammatory responses in vaccinated mice, especially older mice, writing:

“Importantly, aged animals displayed increased eosinophilic immune pathology in the lungs and were not protected against significant virus replication.”

If the Chinese government has been conducting human trials against SARS. MERS, or other coronviruses using recombined viruses, they may have made their citizens far more susceptible to acute respiratory distress syndrome upon infection with 2019-nCoV coronavirus.

The implications are clear: if China sensitized their population via a SARS vaccine, and this escaped from a lab, the rest of world has a serious humanitarian urgency to help China, but may not expect as serious an epidemic as might otherwise be expected.


In the worst-case scenario, if the vaccination strain is more highly contagious and lethal, 2019-nCoV could become the worst example of vaccine-derived contagious disease in human history. With an uncharacteristic aysmptomatic prodromal period of 5-7 days, individuals returning from China to other countries must be forthright and cooperative in their now-prescribed 2-week quarantine.

Well, well, well! Some genuinely new information to consider.

That the infection may be exacerbated by a pre-existing condition specific to Chinese citizenry who received a SARS vaccine?

If that turns out to be the case, then I would imagine the Official World would be somewhat less than receptive to the idea.

It might be wise to let the thought simmer a bit longer, but a ten minute YouTube video with some clear language and helpful graphics could be an interesting item to put into the public domain! -It wouldn't be without precedent; didn't the Zika virus have a lab-based tragedy of errors origin story as well?

-After reading Jon Rappoport's blog, I couldn't help but notice that he's veered rather far into his own brand of hysterics. I'm sure that his Air Pollution/Corruption theory isn't without merit, but it seems the mounting evidence for a genuine infection spread indicates that he's not grappling with the whole picture.
 

Laura

Administrator
Administrator
Moderator
FOTCM Member

At least 19 million people have come down with the flu in the U.S. with 180,000 ending up in the hospital
, according to the Centers for Disease Control and Prevention. The flu season, which started in September and can run until May, is currently at its peak and poses a greater health threat to the U.S. than the new coronavirus, physicians say. The new virus, which first emerged in Wuhan, China, on Dec. 31, has sickened roughly 17,400 and killed 362 people mostly in that country as of Monday morning.

The coronavirus outbreak, however, is proving to be more deadly than the flu. It has killed roughly 2% of the people who have contracted it so far [The article itself explains later on why that isn’t actually true.], according to world health officials. That compares with a mortality rate of 0.095% for the flu in the U.S., according to CDC estimates for the 2019-2020 flu season. The CDC estimates that 21 million people will eventually get the flu this season.

Though some health-care professionals and analysts believe the number of coronavirus cases to be much higher, which would mean a lower mortality rate.


“I think we’re going to find that the mortality number is going to be lower,”
Lighter said. “There is more than likely many times that number of people that have mild (cases) or are asymptomatic.”

“It may end up being comparable to a bad flu season,”
Lighter added.

Naturally, the experts recommend getting your flu shot but, based on the analysis of the coronavirus situation, getting a flu shot might be the last thing you should do!!!
 

Pashalis

Ambassador
Ambassador
FOTCM Member
I was just thinking about the incredible hysteria being promoted and displayed about the Corona-Virus pretty much all over the globe. Could it be that the PTB are using this virus as an opportunity to test how the public reacts and can be handled in case of a real emergency? The absolutely over the top reactions and covering of this Virus just makes you wonder. It is so over the top that you really have to scratch your head. What if it is some sort of dry run for the PTB?
 

nature

Dagobah Resident
Naturally, the experts recommend getting your flu shot but, based on the analysis of the coronavirus situation, getting a flu shot might be the last thing you should do!!!
I agree! Yesterday I saw a man who used to be a very healthy man, never took any medics, never had any flu, cold etc. His doctor adviced and gave him the flu shot. He sadly said "I was never ill till now. My doctor says it's because the flu virus is stronger this year, so I need a second shot said my doctor". "OMG ! " I thought.

Both doctors and patients are mislead. In the other hand, this man felt there is something strange, as he asked me, before walking out my office, with a sad face "What do you think? Do I really need this shot?" I said "... No". Then his sadness cleared from his face, he was relieved. I add "Listen to your heart". He became relieved and he shook my hand very tightly before getting out.
Lots of patients follow blindly their doctor (it's the natural confidence we have in doctors), but these last times I saw some who feel deep inside them that their body/heart says the opposite.
 

angelburst29

The Living Force
The Wuhan Virus Is Not a Lab-Made Bioweapon
The Wuhan Virus Is Not a Lab-Made Bioweapon

LOL. So it's probably a bioweapon then.

The article above seems to be a deliberate attempt to mislead the public that this "Wuhan Coronavirus" is not "a lab-made Bioweapon"
and throw in question, a detailed report by Whitney Webb, showing verifiable evidence that strongly suggests the Coronavirus is man-made and that Pentagon and DARPA are behind the funding.

DARPA recently spent millions on research involving bats and coronaviruses, as well as gene editing “bioweapons” prior to the recent coronavirus outbreak. Now, “strategic allies” of the agency have been chosen to develop a genetic material-based vaccine to halt the potential epidemic.

Bats, Gene Editing and Bioweapons: Recent Darpa Experiments Raise Concerns Amid Coronavirus Outbreak
Bats, Gene Editing and Bioweapons: Recent Darpa Experiments Raise Concerns Amid Coronavirus Outbreak

However, while many of these theories are clearly speculative, there is also verifiable evidence regarding the recent interest of one controversial U.S. government agency in novel coronaviruses, specifically those transmitted from bats to humans. That agency, the Pentagon’s Defense Advanced Research Project Agency (DARPA), began spending millions on such research in 2018 and some of those Pentagon-funded studies were conducted at known U.S. military bioweapons labs bordering China and resulted in the discovery of dozens of new coronavirus strains as recently as last April. Furthermore, the ties of the Pentagon’s main biodefense lab to a virology institute in Wuhan, China — where the current outbreak is believed to have begun — have been unreported in English language media thus far.

As the coronavirus outbreak has come to dominate headlines in recent weeks, several media outlets have promoted claims that the reported epicenter of the outbreak in Wuhan, China was also the site of laboratories allegedly linked to a Chinese government biowarfare program.

However, upon further examination of the sourcing for this serious claim, these supposed links between the outbreak and an alleged Chinese bioweapons program have come from two highly dubious sources.

For instance, the first outlet to report on this claim was Radio Free Asia, the U.S.-government funded media outlet targeting Asian audiences that used to be run covertly by the CIA and named by the New York Times as a key part in the agency’s “worldwide propaganda network.” Though it is no longer run directly by the CIA, it is now managed by the government-funded Broadcasting Board of Governors (BBG), which answers directly to Secretary of State Mike Pompeo, who was CIA director immediately prior to his current post at the head of the State Department. In other words, Radio Free Asia and other BBG-managed media outlets are legal outlets for U.S. government propaganda.

In addition, one preliminary study on the coronavirus responsible for the current outbreak found that the receptor, Angiotensin-converting enzyme 2 (ACE2), is not only the same as that used by the SARS coronavirus, but that East Asians present a much higher ratio of lung cells that express that receptor than the other ethnicities (Caucasian and African-American) included in the study. However, such findings are preliminary and the sample size is too small to draw any definitive conclusions from that preliminary data.

In addition, while both DARPA’s PREEMPT program and the Pentagon’s open interest in bats as bioweapons were announced in 2018, the U.S. military — specifically the Department of Defense’s Cooperative Threat Reduction Program — began funding research involving bats and deadly pathogens, including the coronaviruses MERS and SARS, a year prior in 2017. One of those studies focused on “Bat-Borne Zoonotic Disease Emergence in Western Asia” and involved the Lugar Center in Georgia, identified by former Georgian government officials, the Russian government and independent, investigative journalist Dilyana Gaytandzhieva as a covert U.S. bioweapons lab.

The Pentagon in Wuhan? For instance, one study conducted in Southern China in 2018 resulted in the discovery of 89 new “novel bat coronavirus” strains that use the same receptor as the coronavirus known as Middle East Respiratory Syndrome (MERS). That study was jointly funded by the Chinese government’s Ministry of Science and Technology, USAID — an organization long alleged to be a front for U.S. intelligence, and the U.S. National Institute of Health — which has collaborated with both the CIA and the Pentagon on infectious disease and bioweapons research.

Another U.S. government-funded study that discovered still more new strains of “novel bat coronavirus” was published just last year. Titled “Discovery and Characterization of Novel Bat Coronavirus Lineages from Kazakhstan,” focused on “the bat fauna of central Asia, which link China to eastern Europe” and the novel bat coronavirus lineages discovered during the study were found to be “closely related to bat coronaviruses from China, France, Spain, and South Africa, suggesting that co-circulation of coronaviruses is common in multiple bat species with overlapping geographical distributions.” In other words, the coronaviruses discovered in this study were identified in bat populations that migrate between China and Kazakhstan, among other countries, and is closely related to bat coronaviruses in several countries, including China.

The study was entirely funded by the U.S. Department of Defense, specifically the Defense Threat Reduction Agency (DTRA) as part of a project investigating coronaviruses similar to MERS, such as the aforementioned 2018 study. Yet, beyond the funding of this 2019 study, the institutions involved in conducting this study are also worth noting given their own close ties to the U.S. military and government.

The study’s authors are affiliated with either the Kazakhstan-based Research Institute for Biological Safety Problems and/or Duke University. The Research Institute for Biological Safety Problems, though officially a part of Kazakhstan’s National Center for Biotechnology, has received millions from the U.S. government, most of it coming from the Pentagon’s Cooperative Threat Reduction Program. It is the Kazakhstan government’s official depository of “highly dangerous animal and bird infections, with a collection of 278 pathogenic strains of 46 infectious diseases.” It is part of a network of Pentagon-funded “bioweapons labs” throughout the Central Asian country, which borders both of the U.S.’ top rival states — China and Russia.

Duke University’s involvement with this study is also interesting given that Duke is a key partner of DARPA’s Pandemic Prevention Platform (P3) program, which officially aims “to dramatically accelerate discovery, integration, pre-clinical testing, and manufacturing of medical countermeasures against infectious diseases.” The first step of the Duke/DARPA program involves the discovery of potentially threatening viruses and “develop[ing] methods to support viral propagation, so that virus can be used for downstream studies.”

Duke University is also jointly partnered with China’s Wuhan University, which is based in the city where the current coronavirus outbreak began, which resulted in the opening of the China-based Duke Kunshan University (DKU) in 2018. Notably, China’s Wuhan University — in addition to its partnership with Duke — also includes a multi-lab Institute of Medical Virology that has worked closely with the US Army Medical Research Institute for Infectious Diseases since the 1980s, according to its website. As previously noted, the USAMRIID facility in the U.S. was shut down last July for failures to abide by biosafety and proper waste disposal procedures, but was allowed to partially resume some experiments late last November.

Since the Pentagon began “redesigning” its policies and research towards a “long war” with Russia and China, the Russian military has accused the U.S. military of harvesting DNA from Russians as part of a covert bioweapon program, a charge that the Pentagon has adamantly denied. Major General Igor Kirillov, the head of the Russian military’s radiation, chemical and biological protection unit who made these claims, also asserted that the U.S. was developing such weapons in close proximity to Russian and Chinese borders.

China has also accused the U.S. military of harvesting DNA from Chinese citizens with ill intentions, such as when 200,000 Chinese farmers were used in 12 genetic experiments without informed consent. Those experiments had been conducted by Harvard researchers as part of a U.S. government-funded project.

[...] Furthermore, DARPA and the Pentagon’s past history with bioweapons and their more recent experiments on genetic alteration and extinction technologies as well as bats and coronaviruses in proximity to China have been largely left out of the narrative, despite the information being publicly available. Also left out of the media narrative have been the direct ties of both the USAMRIID and DARPA-partnered Duke University to the city of Wuhan, including its Institute of Medical Virology.

clock.png
29 Jan 2020
author.png
Posted by Ryan Cristián

Above map shown at the 23:34 mark in this video below:

Chinese Nat’l Arrested Smuggling US Bio-Research Vials Into China & Trump’s “Peace” Deal Rejected
Streamed live on Jan 29, 2020 (1:01:02 min.)
 

Pashalis

Ambassador
Ambassador
FOTCM Member
I was just thinking about the incredible hysteria being promoted and displayed about the Corona-Virus pretty much all over the globe. Could it be that the PTB are using this virus as an opportunity to test how the public reacts and can be handled in case of a real emergency? The absolutely over the top reactions and covering of this Virus just makes you wonder. It is so over the top that you really have to scratch your head. What if it is some sort of dry run for the PTB?

And then we also have the rather furious/curious reaction of the Chinese toward all of this. If we believe at this point that the Chinese know how much of it is based on pure hysterics, one wonders of course why they are so incredibly quick and determined in building a huge 60.000 square meter hospital (actually two!) in a matter of 10 days, specifically run by 1.400 military medical staff "because of the virus"? The clinic can work on 1000 patients simultaneously and has 30 emergency rooms. The second hospital will soon be finished too, which isn't much less impressive with 1.500 beds. This one has also been built in 10 days.


Why would the chinese invest so much money and energy into building something like that in 10 days if they know that much of it is hysterics? Maybe they don't know after all? Or is there something else behind it? Maybe the chinese use the opportunity to test out their emergency capabilities in building something like this very fast in case of a real problem? Maybe Corona isn't really the reason for the hospital, but rather a planned dry run for the future, in case something really hist the fan? And then we have the fact that they basically have shut down at least one 10 Million city in a matter of very few days "because of the virus".

I dunno. It is all rather strange to me at this point.
 

Wandering Star

Dagobah Resident
And then we also have the rather furious/curious reaction of the Chinese toward all of this. If we believe at this point that the Chinese know how much of it is based on pure hysterics, one wonders of course why they are so incredibly quick and determined in building a huge 60.000 square meter hospital (actually two!) in a matter of 10 days, specifically run by 1.400 military medical staff "because of the virus"? The clinic can work on 1000 patients simultaneously and has 30 emergency rooms. The second hospital will soon be finished too, which isn't much less impressive with 1.500 beds. This one has also been built in 10 days.


Why would the chinese invest so much money and energy into building something like that in 10 days if they know that much of it is hysterics? Maybe they don't know after all? Or is there something else behind it? Maybe the chinese use the opportunity to test out their emergency capabilities in building something like this very fast in case of a real problem? Maybe Corona isn't really the reason for the hospital, but rather a planned dry run for the future, in case something really hist the fan? And then we have the fact that they basically have shut down at least one 10 Million city in a matter of very few days "because of the virus".

I dunno. It is all rather strange to me at this point.
Totally agree.

Maybe it was "necessary" to build something and fast.

Maybe they expect "something to happen" in a very short time?
 

bjorn

The Living Force
FOTCM Member
Russia to the rescue? Hopefully the Chinese will hand over a life virus soon so that further research can be extended globally to tackle the deadly raging infection.

China tests Russian anti-viral drug which might treat coronavirus as Moscow warns of possible 'mass outbreak'

While health chiefs prepare for a potential pandemic, China is testing a Russian anti-viral drug in the hope that it might help control the new coronavirus. It comes as prospects of a vaccine look slim for the foreseeable future.

Triazavirin, developed at Yekaterinburg’s Ural Federal University, was originally developed to combat ‘Bird Flu’ (H5N1), and, given that there are some similarities between the two infections, researchers feel it’s worth a punt. The medicine is already known to be effective against 15 types of flu.

Russia’s Deputy Health Minister Sergei Kraevoi confirmed the news on Tuesday. He also revealed that the Chinese still haven’t shared samples required for a vaccine with foreign researchers, adding that without these it’s impossible to start looking for a remedy.

“It takes literally several months, from two to five (to conduct preclinical studies),” Kraevoy said. “To do this, you need a live native virus. Unfortunately, at the moment we don’t have this very important living virus,” he explained.


Kraevoi conceded that Russian officials are preparing for a possible large-scale infection, but he gave assurances that the country has sufficient stock of equipment and medicine to deal with the consequences.

Launched in the local market at the end of 2014, it’s claimed Triazavirin is effective against Rift Valley fever and the West Nile virus, in addition to other viral infections. It is also being studied for possible use against Ebola.

The number reported of cases of the new coronavirus (known as 2019-nCoV) worldwide now exceeds 20,600 people with 426 dead in China alone, according to the latest data. The World Health Organization has declared the outbreak a public health emergency.

The main symptoms include a dry cough, weakness, increased body temperature, and difficulty breathing. It was first reported in late December in the Chinese city of Wuhan. The virus is transmitted by droplet transmission, as well as by touching the eyes with hands which have the virus on them.

Russia has, so far, recorded two cases; both of the sufferers are Chinese citizens. In a bid to stop the spread of the infection, authorities have closed the Far Eastern border with China, canceled work and group travel visas for Chinese citizens, shut down passenger railway connections, and heavily restricted flights between the two countries.
 

angelburst29

The Living Force
For instance, the first outlet to report on this claim was Radio Free Asia, the U.S.-government funded media outlet targeting Asian audiences that used to be run covertly by the CIA and named by the New York Times as a key part in the agency’s “worldwide propaganda network.” Though it is no longer run directly by the CIA, it is now managed by the government-funded Broadcasting Board of Governors (BBG), which answers directly to Secretary of State Mike Pompeo, who was CIA director immediately prior to his current post at the head of the State Department. In other words, Radio Free Asia and other BBG-managed media outlets are legal outlets for U.S. government propaganda.

The supposed links between the outbreak and an alleged Chinese bioweapons program have come from two highly dubious sources, both with direct connections to Mike Pompero and ... the Pentagon is funding a biological research institute in Kazakhstan for infectious diseases and now ... Pompeo makes a personal visit to Kazakhstan and Uzbekistan urging them "to rally against China", I'm left with the impression that Pompeo is directly behind and involved with this Coronavirus and what's happening in China? It's like Pompeo has a personal vendetta against China and wants to see it destroyed - internally, as well as, economically and financially. Reduced to ashes!

The study’s authors are affiliated with either the Kazakhstan-based Research Institute for Biological Safety Problems and/or Duke University. The Research Institute for Biological Safety Problems, though officially a part of Kazakhstan’s National Center for Biotechnology, has received millions from the U.S. government, most of it coming from the Pentagon’s Cooperative Threat Reduction Program. It is the Kazakhstan government’s official depository of “highly dangerous animal and bird infections, with a collection of 278 pathogenic strains of 46 infectious diseases.” It is part of a network of Pentagon-funded “bioweapons labs” throughout the Central Asian country, which borders both of the U.S.’ top rival states — China and Russia.

Pompeo urges Kazakhstan to press China over Uighurs Feb. 2, 2020
U.S. Secretary of State Mike Pompeo urged Kazakhstan on Sunday to join Washington in pressing Beijing over its treatment of Muslim minorities, a sensitive matter for the Central Asian nation which has close ties with its neighbor China.

Uzbekistan resists as U.S. seeks to rally Central Asians against China
Uzbekistan on Monday gently resisted Washington's efforts to rally China's central Asian neighbors against Beijing
over its treatment of Muslim minorities, a contentious issue for the region which has close economic ties to China.

Why would the Chinese invest so much money and energy into building something like that in 10 days if they know that much of it is hysterics? Maybe they don't know? Or is there something else behind it? Maybe the chinese use the opportunity to test out their emergency capabilities in building something like this fast in case of a real problem? Maybe Corona isn't really the reason for the hopital but rather a plan for the future, in case something really hist the fan? And than we have the fact that they basically shot down at least one 10 Million city in a matter of very few days "because of the virus".

Maybe because they recognize that the Coronavirus is an engineered bioweapon that specifically targets ethnic Chinese and they need to stop it in it's tracks?

one preliminary study on the coronavirus responsible for the current outbreak found that the receptor, Angiotensin-converting enzyme 2 (ACE2), is not only the same as that used by the SARS coronavirus, but that East Asians present a much higher ratio of lung cells that express that receptor than the other ethnicities (Caucasian and African-American).
 
Top Bottom